Search
Each patient’s expectations for care, for treatment, and for greater longevity are increasing exponentially. As we live longer, our healthcare industry is taking on more and more responsibility for improving lives.
FUJIFILM Healthcare Americas Corporation is dedicated to advancing the ability of healthcare providers to deliver optimal care, ultimately improving patient outcomes. Our healthcare legacy dates back to our founding with the manufacture of X-ray films in 1936. Today, our healthcare offerings span every step from prevention to diagnosis to treatment, including diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. Our extensive portfolio also includes regenerative medicine and life sciences.
Every diagnostic instrument and utility we develop plays a particular role along the care pathway with an eye toward total healthcare. User friendly technologies help increase efficiency and patient throughput. Patient comfort and assurance, as well as helping the flow of medical procedures, are a big part of the general well-being of patients, and our systems are designed particularly with this in mind.
Our commitment to quality – in imaging, in product durability, in the employees hired to serve our customers – sets Fujifilm apart from the rest. With this dedication and commitment, our comprehensive healthcare portfolio touches millions of lives every year. It is the heartbeat in what we do, and we will never stop innovating for a healthier world.
Around the world, this day and tomorrow, millions of people will experience healthcare solutions made more cost effective and efficient by our products and services. And countless more patients will receive drugs from our laboratories that are designed to improve their outcome. Fujifilm is entirely focused on the technologies and therapies that will make this possible.
Commitment to healthcare
FUJIFILM Holdings Corporation has 310 consolidated subsidiaries worldwide – with 73,583 employees – who all contribute to the output of this dynamic organization, working tirelessly to improve the quality of our collective lives.
With global revenues of $29 billion* overall, our Healthcare business alone generates $6.2 billion**, set to rise as populations prosper and grow, and their expectations for healthy lives increase.
* As of March 31, 2023 at an exchange rate of 140 JPY/USD.
** Global Healthcare business revenue include medical devices, pharmaceuticals, contract development and manufacturing, regenerative medicine, cosmetics and supplements. Not all products and services are available in the United States.
 |
 |
| KENJI SUKENO, Chairman, Representative Director and Board Chairman, FUJIFILM Holdings Corporation. |
TEIICHI GOTO, President and Chief Executive Officer, FUJIFILM Holdings Corporation. |
Though often perceived as a film and photography company, Fujifilm developed from its very beginning as a medical imaging specialist.
Our first steps in the development of X-ray film in 1936, and later advances in imaging film and archiving film, set the course for a long line of breakthrough technologies.
The 1980s saw the digital revolution break new ground, bringing a fundamental change in the transmission and sharing of data; Fujifilm developed the world’s first digital X-ray system, bringing new speeds and efficiencies, and achieving wider availability for patients, along with reductions in operational costs.
Toward the end of the 20th century the Internet was born, along with the emergence of dynamic networks, informatics and the management and sharing of data across systems. Fujifilm introduced Synapse® to the market in 1999, combining the revolution in information technology with the networking of diagnostic imaging systems.
The 21st century heralds a new era in pharmacology and we are taking major steps to become a comprehensive healthcare company, adding this integral capability to our portfolio. In 2008, Fujifilm acquired Toyama Chemical, bringing strong expertise in the research and development of drugs to fight infectious and neurological diseases.
All of these diagnostic and therapeutic technologies form a highly connected and holistic approach to healthcare, with the goal of helping patients along the entire care pathway, from the earliest diagnosis right through to the development of new regenerative treatments.
Let us help you find the right product or service that will suit your needs.
